Artificial Intelligence in Biomedicine
Artificial Intelligence (AI) in Biomedicine refers to the use of AI technologies, such as machine learning (ML) and deep learning (DL), to analyze and interpret complex biomedical data. In the short term, AI is making significant contributions to healthcare and biomedical research in several key areas:
Key Areas of AI in Biomedicine:
-
Diagnostics: AI algorithms can analyze medical images (e.g., X-rays, MRIs, CT scans) to detect diseases like cancer, pneumonia, and neurological conditions with high accuracy. AI is also used for diagnosing conditions based on genetic data or patient history.
-
Drug Discovery: AI accelerates the drug development process by predicting how different compounds might interact with targets in the body, identifying potential drug candidates faster than traditional methods.
-
Personalized Medicine: AI helps create personalized treatment plans by analyzing a patient’s genetic makeup, medical history, and lifestyle data to recommend the most effective therapies.
-
Predictive Analytics: AI models can predict disease outbreaks, patient deterioration, or future health risks by analyzing patterns in large datasets, including electronic health records (EHR) and wearable device data.
-
Clinical Trials: AI optimizes the design and recruitment processes for clinical trials, identifying suitable candidates and predicting the trial's outcomes based on patient characteristics and historical data.
Related Conference of Artificial Intelligence in Biomedicine
Artificial Intelligence in Biomedicine Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy
